Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
OLX-101A by OliX Pharmaceuticals for Hypertrophic Scars: Likelihood of Approval
OLX-101A is under clinical development by OliX Pharmaceuticals and currently in Phase II for Hypertrophic Scars. According to GlobalData, Phase...
Data Insights
OLX-101A by OliX Pharmaceuticals for Hypertrophic Scars: Likelihood of Approval
OLX-101A is under clinical development by OliX Pharmaceuticals and currently in Phase II for Hypertrophic Scars. According to GlobalData, Phase...